Pierre Bédossa

Active 1988–2025

Also published as
Pierre Bedossa
207
Papers
64,255
Citations
121
h-index
202
i10-index

Citations

Citations per year for Pierre Bédossa1983: 2 citations1986: 1 citations1989: 1 citations1991: 6 citations1992: 13 citations1993: 11 citations1994: 22 citations1995: 21 citations1996: 42 citations1997: 75 citations1998: 102 citations1999: 129 citations2000: 148 citations2001: 173 citations2002: 240 citations2003: 274 citations2004: 252 citations2005: 285 citations2006: 329 citations2007: 316 citations2008: 401 citations2009: 302 citations2010: 397 citations2011: 440 citations2012: 377 citations2013: 405 citations2014: 435 citations2015: 425 citations2016: 429 citations2017: 402 citations2018: 391 citations2019: 1,218 citations2020: 1,867 citations2021: 2,407 citations2022: 2,392 citations2023: 1,872 citations2024: 3,558 citations2025: 2,100 citations2026: 104 citations1984–1985: no citations, so these years are not shown1987–1988: no citations, so these years are not shown1990: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,785 citing papers, 19.2% of this breakdownChina: 3,159 citing papers, 12.7% of this breakdownItaly: 1,661 citing papers, 6.7% of this breakdownFrance: 1,617 citing papers, 6.5% of this breakdownUnited Kingdom: 1,434 citing papers, 5.8% of this breakdownGermany: 1,286 citing papers, 5.2% of this breakdownJapan: 891 citing papers, 3.6% of this breakdownSpain: 851 citing papers, 3.4% of this breakdownSouth Korea: 641 citing papers, 2.6% of this breakdownAustralia: 580 citing papers, 2.3% of this breakdownCanada: 558 citing papers, 2.2% of this breakdownNetherlands: 451 citing papers, 1.8% of this breakdown
0%19.2%Other 28%

Fields

  • Medicine83.6%
  • Biochemistry, Genetics and Molecular Biology10.6%
  • Immunology and Microbiology2.1%
  • Neuroscience0.6%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Nursing0.4%
  • Other2.2%

Topics

  • Liver Disease Diagnosis and Treatment21.2%
  • Liver Disease and Transplantation5.7%
  • Hepatitis C virus research4.9%
  • Diet, Metabolism, and Disease3.9%
  • Hepatocellular Carcinoma Treatment and Prognosis3.7%
  • Liver Diseases and Immunity2.8%
  • Other57.8%

Coauthors

All papers

Open in search
  1. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vlad Ratziu, Jacob George - Journal of Hepatology 2020 cited by 4,410

  2. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 cited by 1,701

  3. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vincent Wai‐Sun Wong, Vlad Ratziu, Yusuf Yılmaz, Zobair M. Younossi - Gastroenterology 2020 cited by 3,274

  4. NASH limits anti-tumour surveillance in immunotherapy-treated HCC

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pierre Bédossa, Simon Cockell, Ramy Younes, Michèle Vacca, Fabio Marra, Jörn M. Schattenberg, Michael Allison, Elisabetta Bugianesi, Vlad Ratziu, Tiziana Pressiani, Antonio D’Alessio, Nicola Personeni, Lorenza Rimassa, Ann K. Daly, Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein, Arndt Vogel, Markus Peck‐Radosavljevic, Florian Hucke, Fabian Finkelmeier, Oliver Waidmann, Jörg Trojan, Kornelius Schulze, Henning Wege, Sandra Koch, Arndt Weinmann, Marco Bueter, Fabian Rössler, Alexander Siebenhüner, Sara De Dosso, Jan‐Philipp Mallm, Viktor Umansky, Manfred Jugold, Tom Luedde, Andrea Schietinger, Peter Schirmacher, Brinda Emu, Hellmut G. Augustin, Adrian T. Billeter, Beat P. Müller‐Stich, Hiroto Kikuchi, Dan G. Duda, Fabian Kütting, Dirk‐Thomas Waldschmidt, Matthias Ebert, Nuh N. Rahbari, Henrik E. Mei, Axel Schulz, Marc Ringelhan, Nisar P. Malek, Stephan Spahn, Michael Bitzer, Marina Ruiz de Galarreta, Amaia Lujambio, Jean‐François Dufour, Thomas U. Marron, Ahmed O. Kaseb, Masatoshi Kudo, Yi‐Hsiang Huang, Nabil Djouder, Katharina Wolter, Lars Zender, Parice N. Marche, Thomas Decaens, David J. Pinato, Roland Rad, Joachim C. Mertens, Achim Weber, Kristian Unger and 10 more - Nature 2021 cited by 1,280

  5. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

    Authors: , , , , , , , , , , , - Gastroenterology 2019 cited by 1,380

  6. A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 721

  7. Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 442

  8. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Luna Zaru, Leigh MacConell, Reshma Shringarpure, Stephen A. Harrison, Arun J. Sanyal, Manal F. Abdelmalek, Gary A. Abrams, Humberto Aguilar, Aijaz Ahmed, Elmar Aigner, Guruprasad P. Aithal, Aftab Ala, William Alazawi, Agustı́n Albillos, Michael Allison, Sfa Al-Shamma, Raúl J. Andrade, Pietro Andreoné, M. Angélico, Victor Ankoma‐Sey, Quentin M. Anstee, Rodolphe Anty, Víctor Araya, Juan Ignacio Arenas Ruiz, Perttu Arkkila, Marty Arora, Tarik Asselah, Jennifer Au, Oyekoya T. Ayonrinde, Robert J. Bailey, Maya Balakrishnan, Kiran Bambha, Meena B. Bansal, Sidney Barritt, John Bate, Jorge Beato, Susanne Beckebaum, Jaideep Behari, Pablo Bellot, Ziv Ben Ari, Michael Bennett, Marina Berenguer, Benedetta Terziroli Beretta‐Piccoli, Thomas Berg, Maurizio Bonacini, Lucía Bonet, Brian B. Borg, Marc Bourlière, Jérôme Boursier, William D. Bowman, David Bradley, Marija Branković, Marius Braun, Jean-Pierre Bronowicki, Savino Bruno, Elisabetta Bugianesi, Cindy X. Cai, Amy Calderon, José Luis Calleja Panero, Elizabeth J. Carey, Michal Carmiel, J.A. Carrión, Matthew C. Cave, Cristina Chagas, Tawfik N. Chami, Alan K. Chang, Allan Coates, Jeremy Cobbold, Charlote Costentin, Kathleen E. Corey and 288 more - The Lancet 2019 cited by 1,213

  9. A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2024 cited by 423

  10. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Volker Keim, Johannes Wiegand - Journal of Hepatology 2016 cited by 1,246

  11. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

    Authors: , , , , , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2020 cited by 760

  12. Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial

    Authors: , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 235

  13. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2020 cited by 454

  14. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2020 cited by 514

  15. Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guruprasad P. Aithal, Jörn M. Schattenberg, Elisabetta Bugianesi, Manuel Romero‐Gómez, Vlad Ratziu, Quentin M. Anstee, Patrick M. Bossuyt - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 196

  16. An Algorithm for the Grading of Activity in Chronic Hepatitis C

    Authors: , - Hepatology 1996 cited by 4,023

  17. Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anja Geerts, Christophe Moreno, Ulrich Beuers, Peter R. Galle, U. Spengler, Elisabetta Bugianesi, Antonio Craxı̀, M. Angélico, Silvia Fargion, M Voiculescu, Liliana Gheorghe, Liliana Preoțescu, Juan Caballería, Raúl J. Andrade, Javier Crespo, J.L. Callera, Aftab Ala, Guruprasad P. Aithal, George Abouda, Velimir A. Luketic, Mao-Yu Huang, Stuart C. Gordon, Paul J. Pockros, Fred Poordad, Nathan J. Shores, Martin Moehlen, Kiran Bambha, Virginia Clark, Sanjaya K. Satapathy, Samir Parekh, R.K. Reddy, Muhammad Y. Sheikh, Gyöngyi Szabó, John M. Vierling, Timothy E. Foster, Guillermo E. Umpierrez, Chih‐Jen Chang, Terry Box, Juan F. Gallegos‐Orozco - Gastroenterology 2016 cited by 1,014

  18. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Vlad Ratziu, Karine Clément, Raluca Pais, Detlef Schuppan, Jörn M. Schattenberg, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Matej Orešič, Tuulia Hyötyläinen, Aiden McGlinchey, José M. Mato, Óscar Millet, Jean‐François Dufour, Annalisa Berzigotti, Michael Pavlides, Stephen A. Harrison, Stefan Neubauer, Jeremy Cobbold, Ferenc E. Mózes, Salma Akhtar, Rajarshi Banerjee, Matt Kelly, Elizabeth Shumbayawonda, Andrea Dennis, Charlotte Erpicum, Manuel Romero‐Gómez, Emilio Gómez-González, Javier Ampuero, Javier Castell, Rocío Gallego‐Durán, Isabel Fernández-Lizaranzu, Rocío Montero‐Vallejo, M.A. Karsdal, Elisabeth Erhardtsen, Daniel Guldager Kring Rasmussen, Diana Julie Leeming, Mette Juul Fisker, Antonia Sinisi, Kishwar Musa, Fay Betsou, Estelle Sandt, Manuela Tonini, Elisabetta Bugianesi, Chiara Rosso, Angelo Armandi, Fabio Marra, Amalia Gastaldelli, Gianluca Svegliati, Jérôme Boursier, Sven Francque, Luisa Vonghia, Mattias Ekstedt, Stergios Kechagias, Hannele Yki‐Järvinen, Panu K. Luukkonen, Saskia W. C. van Mil, George Papatheodoridis, Helena Cortez‐Pinto, Luca Valenti, Salvatore Petta, Luca Miele, Andreas Geier and 35 more - Journal of Hepatology 2021 cited by 353

  19. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hannes Hagström, Camilla Akbari, Masashi Hirooka, Wah‐Kheong Chan, Sanjiv Mahadeva, Ruveena Bhavani Rajaram, Ming‐Hua Zheng, Jacob George, Mohammed Eslam, Salvatore Petta, Grazia Pennisi, Mauro Viganò, Sofia Ridolfo, Guruprasad P. Aithal, Naaventhan Palaniyappan, Dae Ho Lee, Mattias Ekstedt, Patrik Nasr, Christophe Cassinotto, Victor de Lédinghen, Annalisa Berzigotti, Yuly P. Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier‐Poizat, Andreas Geier, Miljen Martić, Theresa Tuthill, Quentin M. Anstee, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides, Quentin M. Anstee, Ann K. Daly, Olivier Govaere, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Beate K. Straub, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas and 130 more - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 187

  20. Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort

    Authors: , , , , , , , , , , , , , , - Journal of Hepatology 2021 cited by 286

  21. Cenicriviroc Lacked Efficacy to Treat Liver Fibrosis in Nonalcoholic Steatohepatitis: AURORA Phase III Randomized Study

    Authors: , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2023 cited by 148

  22. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients

    Authors: , , , , , , , - Hepatology 2012 cited by 884

  23. Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening

    Authors: , , , , , , , , , , , , , , , , , , - Diabetes Care 2020 cited by 347

  24. An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marta B. Afonso, Ramy Younes, Yuichiro Amano, Scott L. Friedman, Shuang Wang, Dipankar Bhattacharya, Eric J. Simon, Valérie Paradis, Alastair D. Burt, Ioanna Maria Grypari, Susan Davies, Ann Driessen, Hiroaki Yashiro, Susanne Elisabeth Pors, M Andersen, Michael Feigh, Carla Yunis, Pierre Bédossa, Michelle Stewart, Heather Cater, Sara Wells, Jörn M. Schattenberg, Quentin M. Anstee, The LITMUS Investigators, Quentin M. Anstee, Ann K. Daly, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Jo Boyle, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Athanasios Angelakis, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Yong Ook Kim, Beate K. Straub, Antonio Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Mark Campbell, Chris Lelliott, Susan Davies, Matej Orešič, Tuulia Hyötyläinen and 138 more - Nature Metabolism 2024 cited by 229